GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » Valuation Rank

ConvaTec Group (LSE:CTEC) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

ConvaTec Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

ConvaTec Group (LSE:CTEC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » Valuation Rank
Comparable Companies
LSE:AMS LSE:TSTL LSE:BVC LSE:SPEC LSE:CNSL ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM HOLX TSE:7733 COO
Traded in Other Exchanges
CNVVF:USA CNVVY:USA CTECl:UK
Address
23 Forbury Road, 3 Forbury Place, Reading, GBR, RG1 3JH
Website
https://www.convatecgroup.com
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.